Scientific and corporate news
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study
Stroke is a major cause of death and long-term disability, affecting one in six people worldwide. The only currently available approved pharmacological treatment for ischemic
Safety and efficacy of intracoronary treatment with umbilical cord-derived mesenchymal stem cells for very elderly patients with chronic total coronary occlusion
This study aimed to investigate the safety and feasibility of intracoronary injection of human umbilical cord-derived mesenchymal stem cells in very elderly patients with chronic total coronary occlusion into the coronary artery that provides collateral circulation to the heart
Adipose-derived mesenchymal stem cells (AdMSCs) for the treatment of secondary progressive multiple sclerosis: A triple-blind, placebo-controlled, randomized phase I/II safety and feasibility study
Currently available treatments for secondary progressive multiple sclerosis (SPMS) have limited efficacy. Adipose-mesenchymal-derived stem cells (AdMSCs) represent a promising option and can be easily obtained
Stem Cell Storage: Intermediary companies fail, but there are still Biobanks to rely on like SSCB
“The failure and mismanagement of other Biobanks for Stem Cell Preservation ruin our sector”, speaks Dr. Luca Mariotta, Scientific Director of SSCB.
Last week, Ticinonews reported on a young couple who were looking for their baby’s cells after the company they had contracted with, Genico, disappeared. Cantonal pharmacist Giovan Maria Zanini said he was concerned about Switzerland’s free-market policy in such a sensitive area.
50,000 stem cell transplants worldwide
More than 50,000 transplants have been performed worldwide using haematopoietic stem cells. Umbilical cord stem cells are multi-potent cells: unspecialised mother cells, capable of self-renewal and of differentiating into different cell types each with specific functions.
Musculoskeletal disorders and mesenchymal stem cells
Considered to be one of the leading causes of disability worldwide, musculoskeletal disorders include osteoarthritis, rheumatoid arthritis, low back pain, osteoporosis, sarcopenia and myofascial pain